Provided by Tiger Trade Technology Pte. Ltd.

Waters

410.70
+6.011.49%
Volume:816.93K
Turnover:333.47M
Market Cap:40.29B
PE:103.97
High:412.95
Open:400.64
Low:396.00
Close:404.69
52wk High:421.74
52wk Low:282.77
Shares:98.09M
Float Shares:98.09M
Volume Ratio:1.01
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.95
EPS(LYR):10.75
ROE:1.92%
ROA:3.56%
PB:2.65
PE(LYR):38.20

Loading ...

Leerink Partners Adjusts Price Target on Waters to $420 From $430, Maintains Outperform Rating

MT Newswires Live
·
Apr 16

Did Iran Propose Free Passage For Ships In Omani Waters Of Hormuz Strait In A Possible Off-Ramp?

Benzinga_recent_news
·
Apr 16

Waters says BD BACTEC FXI blood culture system wins EU CE mark under IVDR

Reuters
·
Apr 15

Waters Announces Ce Mark for Next-Generation Fully Automated Bd Bactec Fxi Culture System for Bloodstream Infection Diagnosis

THOMSON REUTERS
·
Apr 15

Waters Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Apr 15

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

prnewswire
·
Apr 14

Waters Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Apr 14

Waters Corp Is Maintained at Neutral by UBS

Dow Jones
·
Apr 14

UBS Adjusts Price Target on Waters to $330 From $370, Maintains Neutral Rating

MT Newswires Live
·
Apr 13

Qatar Says Maritime Navigation in Territorial Waters to Resume Sunday -- WSJ

Dow Jones
·
Apr 12

Is Waters (WAT) Price Around US$317 Offering A Compelling Opportunity Today?

Simply Wall St.
·
Apr 10

Waters announces annual shareholder meeting agenda in proxy statement

Reuters
·
Apr 10

Wolfe Research Adjusts Price Target on Waters to $400 From $480, Maintains Outperform Rating

MT Newswires Live
·
Apr 08

Waters Announces FDA Clearance of the Most Comprehensive at-Home Cervical Cancer Screening Tool, the Onclarity Hpv Self-Collection Kit and FDA-Approved Hpv Assay

THOMSON REUTERS
·
Apr 08

Waters says FDA clears Onclarity HPV self-collection kit for at-home screening

Reuters
·
Apr 08

Waters Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 08

Citi Sticks to Its Buy Rating for Waters (WAT)

TIPRANKS
·
Apr 07

Waters upgraded to Outperform from In Line at Evercore ISI

TIPRANKS
·
Apr 06

Evercore ISI Upgrades Waters to Outperform From In Line, Adjusts Price Target to $350 From $360

MT Newswires Live
·
Apr 06

Waters Corp : Evercore Isi Raises to Outperform From in Line; Cuts Target Price to $350 From $360

THOMSON REUTERS
·
Apr 06